Streetbeat News

Earnings

WGS

GeneDx Holdings (NASDAQ:WGS) reported better-than-expected Q3 2024 results with a GAAP EPS of $(0.31), beating the estimate of $(0.50), and sales of $76.87M, surpassing the $64.99M estimate. Sales increased by 44.22% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:02 pm

SYY

Sysco's Q1 2025 earnings per share missed estimates, but sales exceeded expectations. EPS was $1.09, below the $1.13 estimate, while sales were $20.5 billion, surpassing the $20.463 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:01 pm

ECL

Ecolab reported Q3 2024 earnings per share of $1.83, slightly beating the estimate of $1.82. However, sales were $4.00 billion, missing the $4.04 billion estimate. Sales increased by 1.02% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:01 pm

IPGP

IPG Photonics reported its Q3 2024 financial results, with adjusted EPS of $0.29 beating the estimate of $0.20, and sales of $233.143 million surpassing the expected $228.445 million.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:01 pm

PFE

Pfizer reported strong Q3 earnings with a significant increase in revenue and profit, driven by high demand for its COVID-19 products, Paxlovid and Comirnaty. The company raised its 2024 revenue and EPS guidance, expecting $10 billion from COVID products.

Portfolio Pulse from Vandana Singh

October 29, 2024 | 12:01 pm

SEMR

SEMrush Holdings (NYSE:SEMR) has received mixed analyst ratings over the past three months, with a majority being bullish or somewhat bullish. The average 12-month price target has increased by 5.83% to $18.14. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. SEMrush has shown strong financial health with notable revenue growth, net margin, ROE, and ROA, while maintaining a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 12:00 pm

THC

Tenet Healthcare Corporation (THC) has provided guidance for Q4, expecting net operating revenues between $5.007 billion and $5.207 billion, which is below the estimated $5.29 billion. The adjusted EPS is projected to be between $2.69 and $3.31, compared to the estimated $2.88.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 11:59 am

CROX

SHPH

VFC

Shuttle Pharmaceuticals (SHPH) shares surged 91% after finalizing agreements for Phase 2 clinical trials. VF Corporation (VFC) shares rose 23% following better-than-expected Q2 results. Crocs (CROX) shares fell 12% due to disappointing Q3 results and lowered revenue guidance for the HEYDUDE brand.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 11:58 am

BCH

Banco De Chile reported Q3 2024 earnings with a GAAP EPS of $0.64, missing the consensus estimate of $0.69. However, sales were $802.9M, surpassing the expected $796.394M and showing a 4.78% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 11:53 am

TSLA

Tesla is increasingly seen by investors as more than just an auto company, with its stock trading at a high premium due to expected growth in EVs and autonomous driving. Gary Black raised his price target for Tesla, citing improved earnings projections.

Portfolio Pulse from Anan Ashraf

October 29, 2024 | 11:51 am